{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T02:08:06Z","timestamp":1776737286135,"version":"3.51.2"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,13]]},"DOI":"10.7759\/cureus.96792","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:42:56Z","timestamp":1763080976000},"source":"Crossref","is-referenced-by-count":2,"title":["Mesalazine-Induced Myocarditis in a 17-Year-Old: A Case Report"],"prefix":"10.7759","author":[{"given":"Mariam","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirisha","family":"Saripalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Bendakji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1542921","article-title":"Global, regional, and national burden of myocarditis and its attributable risk factors in 204 countries and territories from 1990 to 2021: updated systematic analysis","volume":"13","author":"Ren J","year":"2025","unstructured":"Ren J, Liu W, Jin X, et al.. Global, regional, and national burden of myocarditis and its attributable risk factors in 204 countries and territories from 1990 to 2021: updated systematic analysis. Front Public Health. 2025, 13:1542921. 10.3389\/fpubh.2025.1542921","journal-title":"Front Public Health"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.606509","article-title":"Presentation, patterns of myocardial damage, and clinical course of viral myocarditis","volume":"114","author":"Mahrholdt H","year":"2006","unstructured":"Mahrholdt H, Wagner A, Deluigi CC, et al.. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation. 2006, 114:1581-90. 10.1161\/CIRCULATIONAHA.105.606509","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27631-8","article-title":"Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database","volume":"13","author":"Nguyen LS","year":"2022","unstructured":"Nguyen LS, Cooper LT, Kerneis M, et al.. Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database. Nat Commun. 2022, 13:25. 10.1038\/s41467-021-27631-8","journal-title":"Nat Commun"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahjo.2024.100458","article-title":"Prognosis of myocarditis stratified by initial clinical presentation: does \"intermediate\" risk still play a role?","volume":"46","author":"Di Lisi D","year":"2024","unstructured":"Di Lisi D, Madaudo C, Carmina MG, et al.. Prognosis of myocarditis stratified by initial clinical presentation: does \"intermediate\" risk still play a role?. Am Heart J Plus. 2024, 46:100458. 10.1016\/j.ahjo.2024.100458","journal-title":"Am Heart J Plus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2021-0121","article-title":"Acute myocarditis: aetiology, diagnosis and management","volume":"21","author":"Lampejo T","year":"2021","unstructured":"Lampejo T, Durkin SM, Bhatt N, Guttmann O. Acute myocarditis: aetiology, diagnosis and management. Clin Med (Lond). 2021, 21:e505-10. 10.7861\/clinmed.2021-0121","journal-title":"Clin Med (Lond)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.09.072","article-title":"Cardiovascular magnetic resonance in nonischemic\u00a0myocardial inflammation: expert recommendations","volume":"72","author":"Ferreira VM","year":"2018","unstructured":"Ferreira VM, Schulz-Menger J, Holmvang G, et al.. Cardiovascular magnetic resonance in nonischemic\u00a0myocardial inflammation: expert recommendations. J Am Coll Cardiol. 2018, 72:3158-76. 10.1016\/j.jacc.2018.09.072","journal-title":"J Am Coll Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000001040","article-title":"Diagnostic criteria for myocarditis on cardiac magnetic resonance imaging: an educational review","volume":"85","author":"Joudar I","year":"2023","unstructured":"Joudar I, Aichouni N, Nasri S, Kamaoui I, Skiker I. Diagnostic criteria for myocarditis on cardiac magnetic resonance imaging: an educational review. Ann Med Surg (Lond). 2023, 85:3960-4. 10.1097\/MS9.0000000000001040","journal-title":"Ann Med Surg (Lond)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0800028","article-title":"Myocarditis","volume":"360","author":"Cooper LT Jr","year":"2009","unstructured":"Cooper LT Jr. Myocarditis. N Engl J Med. 2009, 360:1526-38. 10.1056\/NEJMra0800028","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.007405","article-title":"Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document","volume":"13","author":"Ammirati E","year":"2020","unstructured":"Ammirati E, Frigerio M, Adler ED, et al.. Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circ Heart Fail. 2020, 13:e007405. 10.1161\/CIRCHEARTFAILURE.120.007405","journal-title":"Circ Heart Fail"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytad424","article-title":"Mesalazine-induced myopericarditis: a case series","volume":"7","author":"Andrei V","year":"2023","unstructured":"Andrei V, D'Ettore N, Scheggi V, di Mario C. Mesalazine-induced myopericarditis: a case series. Eur Heart J Case Rep. 2023, 7:ytad424. 10.1093\/ehjcr\/ytad424","journal-title":"Eur Heart J Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9813893","article-title":"Myocarditis secondary to mesalamine-induced cardiotoxicity in a patient with ulcerative colitis","volume":"2018","author":"Okoro KU","year":"2018","unstructured":"Okoro KU, Roby MD, Bankole AA. Myocarditis secondary to mesalamine-induced cardiotoxicity in a patient with ulcerative colitis. Case Rep Med. 2018, 2018:9813893. 10.1155\/2018\/9813893","journal-title":"Case Rep Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.14740\/jmc4104","article-title":"Myocarditis related to the use of mesalazine","volume":"14","author":"Kyriakou M","year":"2023","unstructured":"Kyriakou M, Sakellaropoulos S, Constantinides T, Chatzantonis G, Avraamides P, Mitsis A. Myocarditis related to the use of mesalazine. J Med Cases. 2023, 14:237-43. 10.14740\/jmc4104","journal-title":"J Med Cases"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.78208","article-title":"Mesalazine-induced myocarditis in inflammatory bowel disease: a systematic review","volume":"17","author":"Jhakri K","year":"2025","unstructured":"Jhakri K, Al-Shudifat M, Sumra B, Kocherry C, Shamim H, Mohammed L. Mesalazine-induced myocarditis in inflammatory bowel disease: a systematic review. Cureus. 2025, 17:e78208. 10.7759\/cureus.78208","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.970597","article-title":"Analysis of clinical characteristics of mesalazine-induced cardiotoxicity","volume":"13","author":"Chen J","year":"2022","unstructured":"Chen J, Duan T, Fang W, Liu S, Wang C. Analysis of clinical characteristics of mesalazine-induced cardiotoxicity. Front Pharmacol. 2022, 13:970597. 10.3389\/fphar.2022.970597","journal-title":"Front Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2020-000587","article-title":"Recurrent myocarditis in a patient with active ulcerative colitis: a case report and review of the literature","volume":"8","author":"Caio G","year":"2021","unstructured":"Caio G, Lungaro L, Caputo F, et al.. Recurrent myocarditis in a patient with active ulcerative colitis: a case report and review of the literature. BMJ Open Gastroenterol. 2021, 8:10.1136\/bmjgast-2020-000587","journal-title":"BMJ Open Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/429447-mesalazine-induced-myocarditis-in-a-17-year-old-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:42:57Z","timestamp":1763080977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/429447-mesalazine-induced-myocarditis-in-a-17-year-old-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.96792","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,13]]}}}